Home » Newsletters » BioWorld Asia

BioWorld Asia

Oct. 11, 2000

View Archived Issues

Hybrigenics Raises $17.3M For Work In Functional Proteomics

Commission Seeks More Debate On Cloning Before Anarchy Rules

Nerve Growth Factor Could Help Pain Of Diabetes, AIDS

Protherics Gets FDA Approval For Antibody-Based Antivenom

Artemis, Sangamo, Exelixis Link For Knockout Mouse Generation

Phytopharm Considers Options Following Positive Canine Study

Compugen Enters Proteomics With High-Throughput System

Oxford Glyco Finds Heparanase Gene, Seeks To Exploit Discovery

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...